R
|
ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
For
the fiscal year ended December 31, 2008
|
|
£
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
For
the transition period from __________ to
__________
|
Maryland
|
20-3912942
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
No.)
|
|
In
the United States: 11 East 86th Street, New York, New York
10028
In
the People’s Republic of China: Finance Plaza, 9th
Floor, Hi-Tech Road No. 42, Hi-Tech Industrial Development Zone, Xi-An,
China 710068
|
||
(Address of
principal executive
offices)
|
Large accelerated filer o
|
Accelerated filer o
|
Non-accelerated filer o
|
Smaller reporting company þ
|
|
(Do not check if a smaller reporting company)
|
Class
|
Outstanding at March 26,
2009
|
|
Common
Stock, $0.001 par value
|
12,958,574
shares
|
Page
|
||
PART
I
|
||
Item 1.
|
Business.
|
3
|
Item
1A
|
Risk
Factors.
|
7
|
Item 2.
|
Properties.
|
12
|
Item 3.
|
Legal
Proceedings.
|
13
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders.
|
13
|
PART II
|
||
Item 5.
|
Market
for Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities.
|
13
|
Item
6
|
Selected
Financial Data.
|
14
|
Item 7.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operation.
|
14
|
Item 8.
|
Financial
Statements and Supplementary Data.
|
F-1
|
Item 9.
|
Changes
in and Disagreements with Accountants on Accounting and Financial
Disclosure.
|
19
|
Item
9A.
|
Controls
and Procedures.
|
19
|
Item
9B.
|
Other
Information.
|
19
|
PART III
|
||
Item 10.
|
Directors,
Executive Officers, and Corporate Governance.
|
19
|
Item 11.
|
Executive
Compensation.
|
21
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and Related
Stockholder Matters.
|
22
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence.
|
23
|
Item 14.
|
Principal
Accountant Fees and Services.
|
23
|
PART
IV
|
||
Item 15.
|
Exhibits,
Financial Statements Schedules.
|
China
Agri-Business, Inc.
|
||
|
|
100%
ownership
|
|
|
||
Mei
Xin Agri Technology
(Shaanxi)
Co., Ltd.
|
---------------------------------------------------
Contractual
Relationship
(Management
Entrustment Agreement)
|
Shaanxi
Xin Sheng Centennial Agricultural and Technology Co.,
Ltd.
|
Product Brand Name
|
Description and Functionality
|
Plant Suitability
|
Price*
|
|||
Xinsheng
Luyuan
|
A
line of fertilizer product whose primary function is to increase
agricultural production.
|
Wheat,
Rice, Maize, Tobacco, Cotton, Melons and various other fruits
and vegetables.
|
$ 61.56/Box
|
|||
Xinsheng
Lufeng
|
A
line of organic soil amendment products whose primary function is as a
bactericide.
|
Tomatoes
and Apples.
|
$ 38.69/Box
|
|||
Xinsheng
Huang-jin-gai
|
A
line of amino acid fertilizer products designed to help crops absorb
calcium and to improve their overall quality.
|
Tomatoes
and Apples.
|
$ 32.25/Box
|
|||
Xinsheng
Jia-tian-xia
|
A
line of humic acid fertilizer products designed improve the overall
quality of crops
|
Maize,
Cotton, Apples, Tomatos, Watermelon, and various other fruits and
melons.
|
$ 32.25/Box
|
|||
Xinsheng
Bai-le
|
A
line of amino acid fertilizer products designed to provide supplementary
micro-nutrients to crops and to help crops grow with balanced
nutrition.
|
Maize,
Cotton, Apples, Tomatos, Watermelon, and various other fruits
& melons.
|
$ 26.38/Box
|
Registration
No.
|
Trademark/Product
Name
|
Expiration
Date
|
||
No.
(2004) 1485
|
Xinsheng
Luyuan
|
September
2009
|
||
No.
(2004) 1542
|
Xinsheng
Lufeng
|
October
2009
|
||
No.
(2007) 2968
|
Xinsheng
Huang-jin-gai
|
December
2009
|
||
No.
(2007) 2969
|
Xinsheng
Bai-le
|
December
2009
|
||
No.
(2007) 2970
|
Xinsheng
Jia-tian-xia
|
December
2009
|
Company
Name
|
Location
within PRC
|
|
Weifang
Xinde Bio-tech Co., Ltd.
|
Shandong
Province
|
|
Shaanxi
Haide'er Bio-tech Co., Ltd.
|
Shaanxi
Province
|
|
Weifang
Hengsheng Bio-tech Co., Ltd.
|
Shandong
Province
|
|
Zhejiang
Lanhai Bio-engineering Co., Ltd.
|
Zhejiang
Province
|
|
Aiwo
Beijing Agricultural Technology Co., Ltd.
|
Beijing
City
|
|
China
Green Agriculture, Inc.
|
Shaanxi
Province
|
|
Shandong
Dongyan Kefeng Bio-tech Co., Ltd.
|
Shangdong
Province
|
|
Shandong
Tianda Bio-tech Co., Ltd.
|
Shangdong
Province
|
|
Guangxi
Beihai Guofa Bio-tech Co., Ltd.
|
Guangxi
Province
|
Trademark
|
Registration
Number
|
Expiration
Date
|
||
Xinsheng
Shi ji
|
3412688
|
July
2014
|
||
Xinsheng
Luyuan
|
4734942
|
September
2015
|
||
Xinsheng
Lufeng
|
4734940
|
September
2015
|
||
Xinsheng
Huang-jin-gai
|
6213163
|
August
2022
|
||
Xinsheng
Bai-le
|
6212924
|
August
2022
|
||
Xinsheng
Jia-tian-xia
|
6213164
|
August
2022
|
||
New
Agriculture - Generator
|
6952690
|
September
2023
|
High Sales
Price
|
Low Sales
Price
|
|||||||
Year
Ended December 31, 2009:
|
||||||||
1st
Quarter (through March 26, 2009)
|
$ | 0.25 | $ | 0.10 | ||||
Year
Ended December 31, 2008:
|
||||||||
4th
Quarter
|
$ | 0.55 | $ | 0.10 | ||||
3rd
Quarter
|
$ | 0.51 | $ | 0.25 | ||||
2nd
Quarter
|
$ | 1.50 | $ | 0.42 | ||||
1st
Quarter
|
$ | 1.00 | $ | 0.40 | ||||
Year
Ended December 31, 2007:
|
||||||||
4th
Quarter (from October 17, 2007 to December 31, 2007)
|
$ | 2.00 | $ | 0.62 |
2008
|
2007
|
|||||||
Sales
|
$ | 2,922,385 | $ | 3,037,414 | ||||
Cost
of Goods Sold
|
817,472 | 964,961 | ||||||
Gross
Profit
|
$ | 2,104,913 | $ | 2,072,453 | ||||
Gross
Profit Margin
|
72.03 | % | 68.23 | % |
2008
|
2007
|
|||||||
Gross
Profit
|
$ | 2,104,913 | $ | 2,072,453 | ||||
Selling
and marketing
|
316,272 | 146,178 | ||||||
Professional
fees
|
174,869 | 473,809 | ||||||
Depreciation
and amortization expenses
|
60,947 | 61,793 | ||||||
Other
general and administrative
|
177,190 | 347,450 | ||||||
Total
general and administrative
|
729,278 | 1,029,230 | ||||||
Income
from operations
|
1,375,635 | 1,043,223 | ||||||
Interest
expense
|
(58,403 | ) | - | |||||
Interest
income
|
28,107 | 15,659 | ||||||
Net
Income
|
$ | 1,345,339 | $ | 1,058,882 |
Page
|
||
Report
of Independent Registered Public Accounting Firm
|
F-1
|
|
Consolidated
Balance Sheets as of December 31, 2008 and 2007
|
F-2
|
|
Consolidated
Statements of Operations for the Years ended December 31, 2008 and
2007
|
F-3
|
|
Consolidated
Statements of Stockholders’ Equity for the Years ended December 31, 2008
and 2007
|
F-4
|
|
Consolidated
Statements of Cash Flows for the Years ended December 31, 2008 and
2007
|
F-5
|
|
Notes
to Consolidated Financial Statements
|
F-6
- F-17
|
|
/s/
Michael
T. Studer, CPA, P.C.
|
|||
|
Michael
T. Studer, CPA, P.C.
|
|||
|
|
2008
|
2007
|
|||||||
Assets
|
||||||||
Current
Assets
|
||||||||
Cash
and cash equivalents
|
$ | 8,312,636 | $ | 5,984,448 | ||||
Accounts
receivable, net of allowance for doubtful accounts of $6,524
and $23,991, respectively
|
45,165 | 65,118 | ||||||
Inventory
|
47,113 | 60,582 | ||||||
Other
receivables
|
7,329 | 6,855 | ||||||
Prepaid
expenses
|
22,345 | 5,735 | ||||||
Total Current
Assets
|
8,434,588 | 6,122,738 | ||||||
Property,
plant and equipment, net
|
231,278 | 276,000 | ||||||
Investment
in Tienwe Technology
|
879,420 | 822,540 | ||||||
Deferred
financing costs, net of accumulated amortization of $28,403 and $0,
respectively
|
178,879 | - | ||||||
Intangible
assets, net
|
59,495 | 73,554 | ||||||
Total
Assets
|
$ | 9,783,660 | $ | 7,294,832 | ||||
Liabilities
and Stockholders' Equity
|
||||||||
Current
Liabilities
|
||||||||
Accounts
payable and accrued liabilities
|
$ | 234,007 | $ | 166,200 | ||||
Total Current Liabilities
|
234,007 | 166,200 | ||||||
Long
Term Liabilities
|
||||||||
Convertible
notes, net
|
327,020 | - | ||||||
Total Liabilities
|
561,027 | 166,200 | ||||||
Stockholders'
Equity
|
||||||||
Undesignated
preferred stock, par value $.001 per share; authorized 4,900,000 shares;
none issued
|
- | - | ||||||
Common
stock, par value $.001 per share; authorized 100,000,000 shares, issued
and outstanding 12,958,574 and 12,958,574 shares,
respectively
|
12,959 | 12,959 | ||||||
Additional
paid-in capital
|
4,369,786 | 4,150,636 | ||||||
Retained
earnings
|
3,654,212 | 2,308,873 | ||||||
Accumulated
other comprehensive income
|
1,185,676 | 656,164 | ||||||
Total stockholders' equity
|
9,222,633 | 7,128,632 | ||||||
Total Liabilities and
Stockholders' Equity
|
$ | 9,783,660 | $ | 7,294,832 |
2008
|
2007
|
|||||||
Sales
of products
|
$ | 2,922,385 | $ | 3,037,414 | ||||
Cost
of goods sold
|
817,472 | 964,961 | ||||||
Gross
profit
|
2,104,913 | 2,072,453 | ||||||
Selling,
general and administrative expenses
|
729,278 | 1,029,230 | ||||||
Income
from operations
|
1,375,635 | 1,043,223 | ||||||
Interest
and other income
|
28,107 | 15,659 | ||||||
Interest
expense
|
(58,403 | ) | - | |||||
Income
before income taxes
|
1,345,339 | 1,058,882 | ||||||
Income
taxes
|
- | - | ||||||
Net
income
|
1,345,339 | 1,058,882 | ||||||
Deemed
dividend relating to beneficial conversion feature of Series A preferred
stock
|
- | (200,000 | ) | |||||
Net
income attributable to common stockholders
|
$ | 1,345,339 | $ | 858,882 | ||||
Earnings
per common share:
|
||||||||
Basic
|
$ | 0.10 | $ | 0.07 | ||||
Diluted
|
$ | 0.10 | $ | 0.07 | ||||
Weighted
average number of common shares used to compute earnings per common
share:
|
||||||||
Basic
|
12,958,574 | 12,431,496 | ||||||
Diluted
|
13,216,108 | 12,664,099 |
Common
Stock
Shares
|
Common
Stock
Amount
|
Additional
Paid-in
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income
|
Total
|
|||||||||||||||||||
Balance,
December 31, 2006
|
12,278,774 | $ | 12,279 | $ | 3,629,709 | 1,449,991 | $ | 232,272 | $ | 5,324,251 | ||||||||||||||
Sales
of Units in public offering
|
379,800 | 380 | 379,420 | - | - | 379,800 | ||||||||||||||||||
Costs
relating to the public offering
|
- | - | (158,193 | ) | - | - | (158,193 | ) | ||||||||||||||||
Conversion
of Series A preferred stock
|
300,000 | 300 | 99,700 | - | - | 100,000 | ||||||||||||||||||
Deemed
dividend relating to beneficial conversion feature of Series A
preferred stock
|
- | - | 200,000 | (200,000 | ) | - | - | |||||||||||||||||
Net
income for the year ended December 31, 2007
|
- | - | - | 1,058,882 | - | 1,058,882 | ||||||||||||||||||
Foreign
currency translation adjustment
|
- | - | - | - | 423,892 | 423,892 | ||||||||||||||||||
Balance,
December 31, 2007
|
12,958,574 | 12,959 | 4,150,636 | 2,308,873 | 656,164 | 7,128,632 | ||||||||||||||||||
Relative
fair value of warrants and beneficial conversion feature included in sale
of convertible notes
|
- | - | 199,230 | - | - | 199,230 | ||||||||||||||||||
Fair
value of Placement Agent warrants
|
- | - | 19,920 | - | - | 19,920 | ||||||||||||||||||
Net
income for the year ended December 31, 2008
|
- | - | - | 1,345,339 | - | 1,345,339 | ||||||||||||||||||
Foreign
currency translation adjustment
|
- | - | - | - | 529,512 | 529,512 | ||||||||||||||||||
Balance,
December 31, 2008
|
12,958,574 | $ | 12,959 | $ | 4,369,786 | 3,654,212 | $ | 1,185,676 | $ | 9,222,633 |
2008
|
2007
|
|||||||
Operating
activities
|
||||||||
Net
income
|
$ | 1,345,339 | $ | 1,058,882 | ||||
Adjustments
to reconcile net income to net cash provided by (used in) operating
activities:
|
||||||||
Bad
debt expense
|
(18,785 | ) | - | |||||
Depreciation
of property, plant and equipment
|
47,374 | 44,157 | ||||||
Amortization
of intangible assets and deferred financing costs
|
47,726 | 17,636 | ||||||
Amortization
of debt discount and fair value of warrants
|
26,250 | - | ||||||
Changes
in operating assets and liabilities:
|
||||||||
Decrease
in accounts receivable
|
37,420 | 38,726 | ||||||
(Increase)/decrease
in other receivable
|
(474 | ) | 11,621 | |||||
Decrease
in inventory
|
13,469 | 31,671 | ||||||
(Increase)/decrease
in prepaid expenses
|
(16,610 | ) | 16,402 | |||||
Increase
in accounts payable and accrued liabilities
|
67,807 | 114,924 | ||||||
Net
cash provided by operating activities
|
1,549,516 | 1,334,019 | ||||||
Investing
activities
|
||||||||
Loans
receivable collections
|
- | 301,447 | ||||||
Property,
plant and equipment additions
|
(5,300 | ) | (32,902 | ) | ||||
Net
cash (ussed in) provided by investing activities
|
(5,300 | ) | 268,545 | |||||
Financing
activities
|
||||||||
Proceeds
from public offering
|
- | 379,800 | ||||||
Costs
relating to public offering
|
- | (158,193 | ) | |||||
Proceeds
from convertible notes
|
500,000 | - | ||||||
Costs
relating to sale of convertible notes
|
(187,362 | ) | - | |||||
Net
cash provided by financing activities
|
312,638 | 221,607 | ||||||
Effect of exchange rate changes
on cash and cash equivalents
|
471,334 | 374,742 | ||||||
Increase
in cash and cash equivalents
|
2,328,188 | 2,198,913 | ||||||
Cash and cash equivalents,
beginning of period
|
5,984,448 | 3,785,535 | ||||||
Cash and cash equivalents, end
of period
|
$ | 8,312,636 | $ | 5,984,448 | ||||
Supplemental Disclosures of Cash Flow
Informtion:
|
||||||||
Non
Cash Financing Activities:
|
||||||||
Relative
fair value of warrants and beneficial conversion feature recorded as debt
discount and additional paid in capital
|
$ | 199,230 | $ | - | ||||
Fair
value of Placement Agent warrants recorded as deferred financing costs and
additional paid in capital
|
$ | 19,920 | $ | - |
2008
|
2007
|
|||||||
Weighted
average number of common shares outstanding (used to compute basic
EPS)
|
12,958,574 | 12,431,496 | ||||||
Assumed
conversion of redeemable Series A preferred stock - See Note
9
|
- | 232,603 | ||||||
Convertible
notes - See Note 8
|
257,534 | - | ||||||
Weighted
average number of common shares and dilutive common stock equivalents
outstanding (used to compute diluted EPS)
|
13,216,108 | 12,664,099 |
Inventory
consists of:
|
December
31,
|
December
31,
|
||||||
2008
|
2007
|
|||||||
Raw
materials
|
$ | 39,125 | $ | 52,953 | ||||
Finished
goods
|
4,536 | 5,342 | ||||||
Other
|
3,452 | 2,287 | ||||||
Total
inventory
|
$ | 47,113 | $ | 60,582 |
December
31,
|
December
31,
|
|||||||
2008
|
2007
|
|||||||
Building
|
$ | 19,699 | $ | 18,425 | ||||
Transportation
equipment
|
223,092 | 271,081 | ||||||
Manufacturing
equipment and machinery
|
146,034 | 123,798 | ||||||
Office
and computer equipment
|
3,508 | 16,448 | ||||||
392,333 | 429,752 | |||||||
Less
accumulated depreciation
|
161,055 | 153,752 | ||||||
Property,
plant and equipment, net
|
$ | 231,278 | $ | 276,000 |
December
31,
|
December
31,
|
|||||||
2008
|
2007
|
|||||||
Placement
Agent commissions
|
$ | 40,000 | $ | - | ||||
Placement
Agent expense allowance
|
25,000 | - | ||||||
Fair
value of Placement Agent warrants
|
19,920 | - | ||||||
Legal
and other fees
|
122,362 | - | ||||||
Total | 207,282 | - | ||||||
Less:
accumulated amortization
|
(28,403 | ) | - | |||||
Balance
at December 31, 2008
|
$ | 178,879 | $ | - |
December
31,
|
December
31,
|
|||||||
2008
|
2007
|
|||||||
Product
rights
|
$ | 90,141 | $ | 84,310 | ||||
Patent
|
14,657 | 13,709 | ||||||
Trademark
|
2,190 | 1,555 | ||||||
Total
|
106,988 | 99,574 | ||||||
Less
accumulated amortization
|
47,493 | 26,020 | ||||||
Intangible
assets, net
|
$ | 59,495 | $ | 73,554 |
December
31,
2008
|
December
31,
2007
|
|||||||
Convertible
notes - face amount
|
$ | 500,000 | $ | - | ||||
Less:
|
||||||||
Debt
discount attributable to the relative fair value of
warrants
|
(149,615 | ) | - | |||||
Debt
discount attributable to the intrinsic value of the beneficial
conversion feature
|
(49,615 | ) | - | |||||
Less
accumulated amortization of debt discounts
|
26,250 | - | ||||||
Convertible
notes payable, net
|
$ | 327,020 | $ | - |
Year
Ended
December
31, 2008
|
Year
Ended
December
31, 2007
|
|||||||
Outstanding
at beginning of period
|
807,580 | 10,000 | ||||||
Warrants
issued
|
1,080,000 | 797,580 | ||||||
Warrants
exercised
|
- | - | ||||||
Warrants
expired
|
- | - | ||||||
Outstanding
at end of period
|
1,887,580 | 807,580 | ||||||
Exercisable
at end of period
|
1,887,580 | 807,580 |
Date
Issued
|
Expiration
Date
|
Number
of
Warrants
|
Weighted
Average
Exercise
Price
|
|||||||||
May
31, 2006
|
May
31, 2009
|
10,000 | $ | 1.50 | ||||||||
October
11, 2007
|
October
10, 2010
|
379,800 | 1.50 | |||||||||
October
11, 2007
|
October
10, 2010
|
379,800 | 2.00 | |||||||||
October
11, 2007
|
October
10, 2012
|
37,980 | 1.00 | |||||||||
September
29, 2008
|
September
29, 2011
|
80,000 | 1.00 | |||||||||
September
29, 2008 (1)
|
September
29, 2011
|
500,000 | 1.50 | |||||||||
September
29, 2008 (2)
|
-
|
500,000 | 2.00 | |||||||||
Total
|
1,887,580 | $ | 1.70 |
Years
Ended December 31,
|
||||||||
2008
|
2007
|
|||||||
Expected
tax at 35%
|
$ | 470,869 | $ | 383,724 | ||||
Tax
effect of unutilized losses of China Agri and Meixin
|
71,807 | 135,664 | ||||||
Effect
of PRC income tax exemption granted to Xinsheng
|
(387,626 | ) | (349,431 | ) | ||||
Permanent
difference relating to Xinsheng's earnings to be permanently
invested in operations outside the United States
|
(155,050 | ) | (169,957 | ) | ||||
Actual
provision for income taxes
|
$ | - | $ | - |
Year
ending
December
31,
|
Minimum
Rent
|
|||
2009
|
$ | 72,530 | ||
2010
|
68,300 | |||
2011
|
13,425 | |||
Total
|
$ | 154,255 |
NAME
|
POSITION
|
AGE
|
||
Liping
Deng
|
Director,
Chief Executive Officer and President
|
37
|
||
Limin
Deng
|
Chairman
of Board of Directors
|
46
|
||
Xiaolong
Zhou
|
Chief
Financial Officer
|
56
|
||
Michael
Segal
|
Director
|
67
|
NAME
|
POSITION
|
AGE
|
||
Liping
Deng
|
Chairman
of Board of Directors
|
37
|
||
Limin
Deng
|
Vice-Chairman
of Board of Directors
|
46
|
||
Zhengfeng
Guo
|
Director
|
39
|
NAME
|
POSITION
|
AGE
|
||
Liping
Deng
|
Director,
and President
|
37
|
||
Limin
Deng
|
Chairman
of Board of Directors
|
46
|
||
Hong
Cai
|
Director
and Finance Manager
|
42
|
||
Yi
Fu
|
Director
and Vice President
|
36
|
||
Mengzhou
Li
|
Director
|
45
|
Name and Principal
Position
(a)
|
Year
(b)
|
Salary
($)
(c)
|
Bonus
($)
(d)
|
Stock
Awards
($)
(e)
|
Option
Awards
($)
(f)
|
Non-Equity
Incentive
Plan
Compensation
($)
(g)
|
Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
($)
(h)
|
All Other
Compensation
($)
(i)
|
Total
($)
(j)
|
||||||||||||||
Liping
Deng
Chief
Executive Officer (1)
|
2008
|
6,260
|
—
|
—
|
—
|
—
|
—
|
—
|
6,260
|
||||||||||||||
2007
|
5,260
|
—
|
—
|
—
|
—
|
—
|
—
|
5,260
|
|||||||||||||||
Xiaolong
Zhou
Chief
Financial Officer (2)
|
2008
|
45,000
|
—
|
—
|
—
|
—
|
—
|
—
|
45,000
|
||||||||||||||
2007
|
33,750
|
—
|
—
|
—
|
—
|
—
|
—
|
33,750
|
DIRECTOR COMPENSATION
|
||||||||||||||||||||||||||
Name
(a)
|
Fees
Earned or
Paid in
Cash
($)
(b)
|
Stock
Awards
($)
(c)
|
Option
Awards
($)
(d)
|
Non-Equity
Incentive
Plan
Compensation
($)
(e)
|
Non-Qualified
Deferred
Compensation
Earnings
($)
(f)
|
All
Other
Compensation
($)
(g)
|
Total
($)
(j)
|
|||||||||||||||||||
Limin
Deng
|
6,332
|
—
|
—
|
—
|
—
|
—
|
6,332
|
|||||||||||||||||||
Michael
Segal
|
18,000
|
—
|
—
|
—
|
—
|
—
|
18,000
|
·
|
each
person known by us to be the beneficial owner of more than 5% of our
outstanding shares of common stock;
|
·
|
each
of our officers and directors; and
|
·
|
all
our officers and directors as a
group.
|
Name of Beneficial Owner
|
Amount and
Nature of
Beneficial
Ownership
|
Percent of
Class
|
||||||
Michael
Segal
11
East 86th Street
New
York, New York 10028
|
63,074
|
0.5
|
%
|
|||||
Liping
Deng
|
1,851,148
|
14.3
|
%
|
|||||
Liming
Deng
|
—
|
—
|
||||||
Xialong
Zhou
|
—
|
—
|
||||||
All
Directors and Executive Officers as a group (4 persons)
|
1,914,222
|
14.8
|
%
|
|||||
Trustees
for Xinsheng Shareholders (2)
|
9,099,749
|
70.2
|
Exhibit
No.
|
Description
|
31.1
|
Certification
by Chief Executive Officer pursuant to Sarbanes Oxley Section
302.*
|
31.2
|
Certification
by Chief Financial Officer pursuant to Sarbanes Oxley Section
302.*
|
32.1
|
Certification
by Chief Executive Officer pursuant to 18 U.S.C. Section
1350.*
|
32.2
|
Certification
by Chief Financial Officer pursuant to 18 U.S.C. Section
1350.*
|
2008
|
2007
|
|||||||
Audit
Fees (1)
|
$ | 64,400 | $ | 64,400 | ||||
Audit-Related
Fees (2)
|
— | — | ||||||
Tax
Fees (3)
|
— | — | ||||||
All
Other Fees
|
— | — | ||||||
Total
|
$ | 64,400 | $ | 64,400 |
CHINA
AGRI-BUSINESS, INC.
|
|||
By:
|
/s/ Liping Deng
|
||
Liping
Deng
|
|||
President
and Chief Executive Officer
|
|||
(Principal
Executive Officer)
|
|||
By:
|
/s/ Xiaolong Zhou
|
||
Xiaolong
Zhou
|
|||
Chief
Financial Officer
|
|||
(Principal
Accounting Officer)
|
Position
|
Date
|
|||||
By:
|
/s/ Liping Deng
|
President,
Chief Executive Officer, Director
|
March
31, 2009
|
|||
Liping
Deng
|
||||||
By:
|
/s/ Xiaolong Zhou
|
Chief
Financial Officer
|
March
31, 2009
|
|||
Xiaolong
Zhou
|
||||||
By:
|
/s/ Limin Deng
|
Director
|
March
31, 2009
|
|||
Limin
Deng
|
||||||
By:
|
/s/ Michael Segal
|
Director
|
March
31, 2009
|
|||
Michael
Segal
|
||||||